BioNanoTech

company

About

BioNanoTech, A Leader in Protein/Antibody Purification & Biological Testing Technology. Rapid Drug R&D and Production for the World.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
B2B,Biopharma,Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

At BioNanoTech, we are on a mission to save lives. We have solved the single most significant hurdle for biologic drug discovery. Our revolutionary size-invariant, ultra-high purity, and high yield protein and antibody purification technology platform unlocks the $265B market. Our platform creates new pathways for drug and vaccine discovery, production, and biological testing at a fraction of the previous lifetime costs. Our technology empowers the pharmaceutical and scientific community to expand their current production and revisit previous low-yield lines at the production scale, exposing new opportunities and turning waste into revenue so that no cure is left behind.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$225K
BioNanoTech has raised a total of $225K in funding over 2 rounds. Their latest funding was raised on Dec 23, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 23, 2017 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
BioNanoTech is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant